Note: This is an archived Handbook entry from 2009. Search for this in the current handbook
|Dates & Locations:|| |
This subject has the following teaching availabilities in 2009:Semester 2, - Taught on campus.
Timetable can be viewed here. For information about these dates, click here.
|Time Commitment:||Contact Hours: three x 1 hour lecture and one x 1 hour tutorial per week |
Total Time Commitment: 48 contact hours with an estimated total time commitment of 120 hours
Other combinations of subjects that provide a similar background may be considered by the coordinator.
|Recommended Background Knowledge:||None|
|Non Allowed Subjects:||Students cannot enrol in and gain credit for this subject if previously obtained credit for pre-2009 subject (521-304) Hormone and Neurotransmitter Biochemistry|
|Core Participation Requirements:||It is University policy to take all reasonable steps to minimise the impact of disability upon academic study and reasonable steps will be made to enhance a student’s participation in the University’s programs. Students who feel their disability may impact upon their active and safe participation in a subject are encouraged to discuss this with the relevant subject coordinator and the Disability Liaison Unit.|
CoordinatorAssoc Prof Heung-Chin Cheng
Aberrations in the structure and expression of hormones, growth factors, neurotransmitters and their receptors can give rise to diseases such as cancer and neurodegenerative diseases. To understand the molecular basis of these diseases, it is essential to know how hormones, growth factors and neurotransmitters are synthesised, and how their signals are recognised, amplified and transmitted by intracellular signalling pathways in the target cells.
Topics covered include structures of hormone and neurotransmitter receptors, mechanisms of intracellular signal transduction, second messengers and protein phosphorylation-dephosphorylation; regulation of gene expression; molecular basis of drug addiction; different roles of individual neurotransmitters; neurochemistry of sensory transduction, mechanism of neuronal apoptosis and necrosis, molecular basis of neurodegenerative disease, molecular basis of cancer formation and progression and the use and design of protein kinase inhibitors as therapeutics for treatment of cancer and neurodegenerative diseases.
On completion of the subject:
3 hour written exam held in examination period (70%), two 1 hour written examinations held during semester (7.5% x 2 = 15%), Oral presentation (7.5%), 1,000 word written assignment (7.5%)
|Prescribed Texts:||Basic Neurochemistry 7th edition, Elsevier by Siegel, G,J., Abers, R.W., Brady, S.T. and Price, D.L.|
|Breadth Options:|| |
This subject is not available as a breadth subject.
|Fees Information:||Subject EFTSL, Level, Discipline & Census Date|
On completion of this subject, students should have developed the following generic skills:
Students enrolled in the BSc (pre-2008 BSc), BASc or a combined BSc course will receive science credit for the completion of this subject.
Students undertaking this subject will be expected to regularly access an Internet-enabled computer
Bachelor of Biomedical Science |
Graduate Diploma in Biotechnology
Biochemistry and Molecular Biology |
Reproduction and Development
Download PDF version.